SCHEMBL7549706

SCHEMBL7549706

NC(=O)N(c1ccccc1)c1ccc(N)cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPT P10636 4/20 0.43
KDM4E B2RXH2 4/20 0.43
GAA P10253 2/20 0.43
ESR2 Q92731 2/20 0.43
PTPN1 P18031 1/20 0.43
KDR P35968 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
TBXA2R P21731 1/20 0.42
SLC6A2 P23975 1/20 0.42
PDE4A P27815 1/20 0.42
ADRA1A P35348 1/20 0.42
SLC6A3 Q01959 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27576158 0.83 KDM4E (0.46) ALDH1A1MAPTKDM4EGAAESR2
SCHEMBL6823836 0.83 ESR1 (0.40) ALDH1A1ESR2NPSR1TDP1KMT2A
SCHEMBL28100008 0.83 CYP3A4 (0.50) CYP3A4ALDH1A1MAPTKDM4EGAA
SCHEMBL9267992 0.81 NPSR1 (0.48) CYP3A4ALDH1A1MAPTKDM4EGAA
SCHEMBL27587702 0.81 MGLL (0.45) ALDH1A1MAPTGAALMNATP53
SCHEMBL8982765 0.81 KDM4E (0.35) CYP3A4ALDH1A1MAPTKDM4EGAA
SCHEMBL27605653 0.81 CYP3A4 (0.44) CYP3A4ALDH1A1MAPTGAAKDR
SCHEMBL27519458 0.80 MAPT (0.37) CYP3A4ALDH1A1MAPTKDM4EGAA
SCHEMBL27516971 0.79 POLQ (0.40) ALDH1A1MAPTKDM4ENPSR1KMT2A
SCHEMBL27498642 0.79 CXCR2 (0.44) ALDH1A1PTPN1NPSR1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128321-A1 IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128321-A1 IL-8 receptor antagonists CXCL8, CCR8, IL1RN CYP3A4 2725/4885ALDH1A1 2239/4885MAPT 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.